Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms.
about
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.The role of dehydroepiandrosterone in diabetes mellitus.Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans.Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome.Correlation between Expression of Glucose Transporters in Granulosa Cells and Oocyte Quality in Women with Polycystic Ovary Syndrome.Adrenal responsiveness to high, low and very low ACTH 1-24 doses in obesity.Oral glucose challenge effects on growth and sex steroid hormones in normal women and women with hypothalamic amenorrhea.Effect of growth hormone suppression on the serum levels of ovarian and adrenal sex steroid hormones in normal women and in women with polycystic ovary syndrome.Decreased androgen levels and obesity in men.Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome.Dehydroepiandrosterone sulphate is increased and dehydroepiandrosterone-response to corticotrophin-releasing hormone is decreased in the hyperthyroid state compared with the euthyroid state.Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.Appetite and endocrine regulators of energy balance after 2 days of energy restriction: insulin, leptin, ghrelin, and DHEA-S.Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia.Relationship between type 2 diabetes mellitus and hypothalamic-pituitary-adrenal axis.Androgens and cardiovascular disease in men and women
P2860
Q33569169-FF01A7E5-4094-4AD0-A57B-8DA82BEDC47CQ33637246-9DB0D91B-5C3D-49D9-A328-D360F031878AQ34189359-9E1E9F48-CBB5-462E-9B25-4BED6A9A41CBQ36951616-8DA33642-647F-4E74-A6AD-F43206A086F7Q37673437-AFD9E57D-18D6-44B6-9AD1-DC6203EAA090Q38307987-1A80CCD0-1A32-44C4-BF31-4EFCE3FA7745Q39506527-3B0315D5-0ED4-4882-ACBF-D77762BD5A31Q39506531-5CBA45ED-16DC-4331-8578-C8E9104E0F2FQ41227268-D1F66B08-B0AF-4301-8FA4-E1E71F1F6635Q42489607-EDB58BA2-E2E8-45CA-BF45-5F151D8DC64CQ43918206-F98CA4B1-A3C4-4105-831E-55A64811CA0DQ44424877-14147279-75DD-4EE5-BADD-5BA1387516E5Q44515923-FBCABD3C-E992-4DE8-8202-7D1FE2641633Q51566103-E2ABE743-87F6-4D4B-AFC8-7E1EC907D21CQ51623907-526C7E70-5601-472B-AB7E-0877E57AE499Q58248183-300C017F-1F40-4E72-814C-000C83495EA6
P2860
Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Suppression of serum dehydroep ...... uation of possible mechanisms.
@en
Suppression of serum dehydroep ...... uation of possible mechanisms.
@nl
type
label
Suppression of serum dehydroep ...... uation of possible mechanisms.
@en
Suppression of serum dehydroep ...... uation of possible mechanisms.
@nl
prefLabel
Suppression of serum dehydroep ...... uation of possible mechanisms.
@en
Suppression of serum dehydroep ...... uation of possible mechanisms.
@nl
P2093
P356
P1476
Suppression of serum dehydroep ...... uation of possible mechanisms.
@en
P2093
P304
P356
10.1210/JCEM-69-5-1040
P407
P577
1989-11-01T00:00:00Z